Areas of Focus
- Antiviral Drugs
Work Experience
- 2021-11 to Present - Institute of Microbiology, Chinese Academy of Sciences - Associate Researcher
- 2016-07 to 2021-11 - Institute of Microbiology, Chinese Academy of Sciences - Assistant Researcher
- 2009-09 to 2016-07 - Institute of Microbiology, Chinese Academy of Sciences - Ph.D. in Science
- 2005-09 to 2009-07 - China Agricultural University - Bachelor's in Science
Academic Background & Achievements
- 2009-09 to 2016-07 Ph.D. in Science: Institute of Microbiology, Chinese Academy of Sciences
- 2005-09 to 2009-07 Bachelor's in Science: China Agricultural University
Publications
- Systematic identification of chemical components in Fufang Shuanghua oral liquid and screening of potential active components against SARS-CoV-2 protease, 11th Author, 2023
- Mechanism of Microbial Metabolite Leupeptin in the Treatment of COVID-19 by Traditional Chinese Medicine Herbs, 1st Author, 2021
- Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir, 6th Author, 2021
- Structure-based design of 5 '-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitors, 4th Author, 2021
- Multiple RNA virus matrix proteins interact with SLD5 to manipulate host cell cycle, 4th Author, 2021
- Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir, 11th Author, 2021
- Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease, 1st Author, 2020
- Chemical modification and fluorescence labeling of Escherichia coli cell wall peptidoglycan, 5th Author, 2020
- Avian-to-Human Receptor-Binding Adaptation of Avian H7N9 Influenza Virus Hemagglutinin, 10th Author, 2019
- Influenza virus matrix protein M1 interacts with SLD5 to block host cell cycle, 8th Author, 2019
- Constitutive expression of StAATP, a potato plastidic ATP/ADP transporter gene, increases starch content in transgenic Arabidopsis, 2nd Author, 2017
- Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor, 5th Author, 2016
- Structure-based tetravalent zanamivir with potent inhibitory activity against drug-resistant influenza viruses, 1st Author, 2016
- AtMYB12 regulates flavonoids accumulation and abiotic stress tolerance in transgenic Arabidopsis thaliana, 4th Author, 2016
- Glycosynthase with Broad Substrate Specificity - an Efficient Biocatalyst for the Construction of Oligosaccharide Library, 5th Author, 2013
Awards
- Pathogenic Microorganisms and Immunology Key Laboratory Annual Scientific Achievement Award (2020): Special Prize, Institute
